Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TIS”

97 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 97 results

Not applicableUnknownNCT03737578
What this trial is testing

Comparison of Daily Home Hemodialysis (HD) With Conventional in Center HD in Terms of Patients Quality of Life and Clinical Outcomes

Who this might be right for
End Stage Renal Disease
Physidia 160
Not applicableWithdrawnNCT01460849
What this trial is testing

Assess Increased Mortality Risk With Each Year of Delayed Tobramycin Solution (TIS) Initiation, and Effect of TIS on Mortality Across Study Centers

Who this might be right for
Cystic Fibrosis
Novartis Pharmaceuticals
Not applicableStudy completedNCT01560078
What this trial is testing

Efficacy Study of Thrice Weekly Directly Observed Treatment Short-Course Regimen in Tubercular Pleural Effusion

Who this might be right for
TuberculosisPleural Effusion
All India Institute of Medical Sciences 360
Early research (Phase 1)Study completedNCT00323934
What this trial is testing

Study of MGCD0103 Given Three-Times Weekly in Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
TumorsNon Hodgkin's Lymphoma
Mirati Therapeutics Inc. 42
Not applicableNot Yet RecruitingNCT07361250
What this trial is testing

Subthalamic Nucleus (STN) Targeted Transcranial Temporal Interference Stimulation (TIS) Treats Parkinson's Disease

Who this might be right for
Parkinson Disease
Tang Zhouping 20
Not applicableLooking for participantsNCT03392337
What this trial is testing

An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients

Who this might be right for
Psoriasis
Psoriasis Treatment Center of Central New Jersey 30
Not applicableNot Yet RecruitingNCT04275102
What this trial is testing

Three Times Weekly Symptom Screening for Children With Cancer

Who this might be right for
CancerRelapsed Cancer
The Hospital for Sick Children 30
Large-scale testing (Phase 3)Study completedNCT00048451
What this trial is testing

Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)

Who this might be right for
Renal Insufficiency, Chronic
Abbott 68
Testing effectiveness (Phase 2)Study completedNCT01121731
What this trial is testing

A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C Virus InfectionGenotype 1Treatment-Experienced Patients+1 more
Digna Biotech S.L. 70
Early research (Phase 1)Study completedNCT04671030
What this trial is testing

Use of a Prokinetic Agent as an Adjunct to Thrice Weekly Bowel Care After SCI

Who this might be right for
Spinal Cord InjuriesConstipationNeurogenic Bowel
James J. Peters Veterans Affairs Medical Center 6
Large-scale testing (Phase 3)Study completedNCT00943995
What this trial is testing

Three Times Weekly (TIW) Growth Hormone Therapy in Children on Hemodialysis

Who this might be right for
Kidney Failure, ChronicRenal Dialysis
Nationwide Children's Hospital 3
Not applicableLooking for participantsNCT06607432
What this trial is testing

Temporal Interference Stimulation for Social Cognition

Who this might be right for
Healthy Controls
Columbia University 30
Large-scale testing (Phase 3)Study completedNCT03740048
What this trial is testing

A Pilot Trial of Twice-weekly Versus Thrice-weekly Hemodialysis in Patients With Incident End-stage Kidney Disease

Who this might be right for
End Stage Renal Failure on Dialysis
Wake Forest University Health Sciences 51
Testing effectiveness (Phase 2)Study completedNCT00023283
What this trial is testing

Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1

Who this might be right for
Heroin DependenceOpioid-Related DisordersSubstance Abuse, Intravenous
Yale University
Not applicableLooking for participantsNCT06461260
What this trial is testing

Amygdala MRI-TIS for Depression

Who this might be right for
Major Depressive Disorder
Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University 30
Testing effectiveness (Phase 2)Study completedNCT02159859
What this trial is testing

Pharmacokinetics and Optimal Dose of Ertapenem in Hemodialysis Patients

Who this might be right for
End Stage Renal Disease
Corewell Health East 7
Not applicableStudy completedNCT02308670
What this trial is testing

Evaluate the Effect of Switching From Daily Injections of 20mg Glatiramer Acetate (GA) to 40mg GA Three Times a Week in Subjects With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University at Buffalo 150
Large-scale testing (Phase 3)Study completedNCT01742013
What this trial is testing

Investigator Initiated Clinical Study to Explore the Efficacy and Safety of Human Placenta Hydrolysate in the Chronic Fatigue Patients

Who this might be right for
Chronic Fatigue SyndromeIdiopathic Chronic Fatigue
Ho Cheol Shin, M.D., Ph.D. 78
Testing effectiveness (Phase 2)Study completedNCT01299610
What this trial is testing

Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a Placebo

Who this might be right for
Dermatitis, Atopic
GlaxoSmithKline 25
Large-scale testing (Phase 3)Study completedNCT00548405
What this trial is testing

Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Genzyme, a Sanofi Company 840
Load More Results